It's time to deal with pharma's image problem, former exec argues

04/21/2013 | Forbes

PhRMA members can enhance the industry's image by making clinical trial results available to the public, writes former Pfizer Global Research President John LaMattina in an open letter to PhRMA. Also, putting a human face of the life-changing research done by pharmaceutical scientists would help, he writes. "Not many have had the chance to see the good that this industry does," LaMattina writes. "[U]nless these beliefs are changed, people will view our products as overpriced drugs with little potential benefit and with hidden safety issues."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI